Skip to main content
FinSpry Logo
FinSpry
VCYT logo
VCYT
(NASDAQ)
Veracyte, Inc.
$32.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Veracyte (VCYT) Stock Price & Financial Analysis

Veracyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$31.48 - $33.18
52-Week High$50.71
52-Week Low$22.61
Open$31.48
Volume702.90K
Average Volume (3M)702.90K
Market Cap2.60B
Shares Outstanding80.57M
P/E Ratio (TTM)39.34
Forward P/E19.87
Price to Sales (P/S)5.05
Price to Book (P/B)1.99
EV/EBITDA27.45
Revenue (TTM)517.14M
Net Income (TTM)66.35M
Free Cash Flow (TTM)126.10M
EPS (TTM)$0.82
Profit Margin12.83%
Operating Margin12.48%
Return on Equity (ROE)5.07%
Debt to Equity0.03
50-Day MA$35.50
200-Day MA$34.87
52-Week Change9.61%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Veracyte

What is the current stock price for VCYT?

As of the latest trading session, VCYT stock trades at $32.25. The 52-week range is $22.61–$50.71, with a day range of $31.48–$33.18.

What is the P/E ratio for VCYT?

Veracyte's trailing P/E ratio is 39.3, meaning investors pay $39.3 for every $1 of annual earnings. The forward P/E is 19.9, reflecting analyst expectations for future earnings. Veracyte operates in the Healthcare sector.

Does VCYT pay dividends?

Veracyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCYT?

Based on 3 analysts, the consensus for VCYT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VCYT?

Veracyte's market capitalization is $2.60B, classifying it as a mid-cap company. Veracyte operates in the Healthcare sector within the Diagnostics & Research industry.